PL434153A1 - Kompozycja zawierająca kannabinoidy - Google Patents

Kompozycja zawierająca kannabinoidy

Info

Publication number
PL434153A1
PL434153A1 PL434153A PL43415320A PL434153A1 PL 434153 A1 PL434153 A1 PL 434153A1 PL 434153 A PL434153 A PL 434153A PL 43415320 A PL43415320 A PL 43415320A PL 434153 A1 PL434153 A1 PL 434153A1
Authority
PL
Poland
Prior art keywords
composition containing
aqueous solutions
cannabinoids
containing cannabinoids
monodispersion
Prior art date
Application number
PL434153A
Other languages
English (en)
Other versions
PL245030B1 (pl
Inventor
Grzegorz Andrzej KIEŁBOWICZ
Paweł Mituła
Tomasz Tronina
Original Assignee
Healthcann Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Healthcann Spółka Z Ograniczoną Odpowiedzialnością filed Critical Healthcann Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL434153A priority Critical patent/PL245030B1/pl
Priority to CA3180908A priority patent/CA3180908A1/en
Priority to PCT/PL2021/050035 priority patent/WO2021246884A1/en
Priority to EP21754853.6A priority patent/EP4157258A1/en
Priority to US17/928,952 priority patent/US20230218645A1/en
Publication of PL434153A1 publication Critical patent/PL434153A1/pl
Publication of PL245030B1 publication Critical patent/PL245030B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3482—Cannabis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Botany (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Przedmiotem zgłoszenia są samoemulgujące kompozycje tworzące stabilne monodyspersje w roztworach wodnych zawierające względnie wysokie stężenia kannabinoidów. Mogą być one łatwo rozcieńczane w roztworach wodnych. Dzięki temu nadają się do wytwarzania produktów doustnych na bazie wody, zwłaszcza kompozycji farmaceutycznych, wyrobów medycznych lub produktów spożywczych.
PL434153A 2020-06-01 2020-06-01 Samoemulgująca się kompozycja zawierająca kannabinoidy, jej zastosowanie, stabilny układ monodyspersyjny oraz sposób jego wytwarzania PL245030B1 (pl)

Priority Applications (5)

Application Number Priority Date Filing Date Title
PL434153A PL245030B1 (pl) 2020-06-01 2020-06-01 Samoemulgująca się kompozycja zawierająca kannabinoidy, jej zastosowanie, stabilny układ monodyspersyjny oraz sposób jego wytwarzania
CA3180908A CA3180908A1 (en) 2020-06-01 2021-06-01 Composition containing cannabinoids
PCT/PL2021/050035 WO2021246884A1 (en) 2020-06-01 2021-06-01 Composition containing cannabinoids
EP21754853.6A EP4157258A1 (en) 2020-06-01 2021-06-01 Composition containing cannabinoids
US17/928,952 US20230218645A1 (en) 2020-06-01 2021-06-01 Composition containing cannabinoids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL434153A PL245030B1 (pl) 2020-06-01 2020-06-01 Samoemulgująca się kompozycja zawierająca kannabinoidy, jej zastosowanie, stabilny układ monodyspersyjny oraz sposób jego wytwarzania

Publications (2)

Publication Number Publication Date
PL434153A1 true PL434153A1 (pl) 2021-12-06
PL245030B1 PL245030B1 (pl) 2024-04-22

Family

ID=77317389

Family Applications (1)

Application Number Title Priority Date Filing Date
PL434153A PL245030B1 (pl) 2020-06-01 2020-06-01 Samoemulgująca się kompozycja zawierająca kannabinoidy, jej zastosowanie, stabilny układ monodyspersyjny oraz sposób jego wytwarzania

Country Status (5)

Country Link
US (1) US20230218645A1 (pl)
EP (1) EP4157258A1 (pl)
CA (1) CA3180908A1 (pl)
PL (1) PL245030B1 (pl)
WO (1) WO2021246884A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12365525B2 (en) * 2022-11-25 2025-07-22 Seyed AmirAli Anvar Apparatus and method for producing nanoemulsions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
WO2008019146A2 (en) * 2006-08-04 2008-02-14 Insys Therapeutics Inc. Aqueous dronabinol formulations
US20180318399A1 (en) * 2015-07-23 2018-11-08 Matoke Holdings Limited Antimicrobial compositions and formulations releasing hydrogen peroxide
US20190070124A1 (en) * 2016-03-04 2019-03-07 Sharon Anavi-Goffer Compositions of cb2 receptor selective agonists for treatment of mental disorders
US20200330378A1 (en) * 2018-01-03 2020-10-22 Icdpharma Ltd. Taste-enhanced cannabinoid submicron emulsion syrup compositions
US20200022386A1 (en) * 2018-07-17 2020-01-23 Pharcon Inc. Method of preparation of cannabinoids containing beverages

Also Published As

Publication number Publication date
PL245030B1 (pl) 2024-04-22
EP4157258A1 (en) 2023-04-05
WO2021246884A1 (en) 2021-12-09
CA3180908A1 (en) 2021-12-09
US20230218645A1 (en) 2023-07-13

Similar Documents

Publication Publication Date Title
PH12018502747A1 (en) Boronic acid derivatives and therapeutic uses thereof
CO6680698A2 (es) Formulación de premezcla de dexmedetomidina
CL2020000632A1 (es) Composición y método para el tratamiento del autismo.
WO2015171460A3 (en) Formulations of cyclophosphamide liquid concentrate
BR112018009297A8 (pt) composição de limpeza e desinfecção
WO2016105564A8 (en) Quinazoline derivatives used to treat hiv
BR112012021873B8 (pt) composição de matéria, artigo de manufatura, métodos para preparar uma composição, para aumentar a estabilidade de uma proteína em solução aquosa livre de polissorbato e para prevenir ou reduzir a agregação de uma proteína em solução aquosa livre de polissorbato
NZ743964A (en) Aqueous pharmaceutical formulation comprising anti-pd-1 antibody avelumab
NO20082269L (no) Nye piperaziner som antimalariamidler
MX378687B (es) Formulacion de vitamina soluble en grasa.
CL2018003418A1 (es) Formulaciones de óxido de polialquileno-asparaginasa y métodos de preparación y uso del mismo.
PE20200478A1 (es) Nuevas formulaciones y composiciones de cannabis en comprimidos y metodos para su elaboracion
BR112013019394A2 (pt) uso de um agente
BR112014003264A2 (pt) composições nutricionais compreendendo uma fibra viscosa solúvel e um extrato de planta contendo polifenol
AR092691A1 (es) Composicion farmaceutica que comprende rebamipida
AR087371A1 (es) Formulaciones de (trimetoxifenilamino)pirimidinilo, metodos
PL434153A1 (pl) Kompozycja zawierająca kannabinoidy
CO2018010937A2 (es) Sistemas de formulación para glicolípidos antimicrobianos
AR101673A1 (es) Composición para el tratamiento de neuropatías y del dolor neuropático
BR112015013756A2 (pt) óleos essenciais solúveis em água e seu uso
SA522432861B1 (ar) صياغات تشتمل على معدن و/أو فيتامين وبولي سكاريد، تركيبات منها واستخدامها في المعدن و/أو الفيتامين المُكمل المذكور
JOP20250075A1 (ar) تركيبة دالبافانسين سائلة
DOP2021000069A (es) Derivados de 4 pirazin-2-ilmetil-morfolina y su uso como medicamento
MY160904A (en) Piperazines as antimalarial agents
GEAP201814134A (en) Crystalline forms of s-acetyl glutathione, their reparations and uses in pharmaceutical and nutraceutical formulations